Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lobe Sciences Ltd
(CSE:
LOBE
)
0.1100
+0.0100 (+10.00%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Jul 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Lobe Sciences Ltd
< Previous
1
2
3
Next >
Lobe Sciences Files Management Information Circular for Annual General and Special Meeting on July 30, 2026
July 07, 2026
From
Lobe Sciences Ltd.
Via
ACCESS Newswire
Lobe Sciences Directors and Management Increase Equity Ownership Through Settlement of Accrued Fees by the Issuance of Common Shares
June 09, 2026
Via
ACCESS Newswire
Lobe Sciences Announces Proposed Shares for Debt Transaction
June 01, 2026
Via
ACCESS Newswire
Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
May 06, 2026
Via
ACCESS Newswire
Lobe Sciences Reports Second Quarter 2026 Results and Highlights Continued Operational Progress
May 06, 2026
Via
ACCESS Newswire
Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
April 23, 2026
Via
ACCESS Newswire
Lobe Sciences Ltd. Engages Massive Intelligence Pty Ltd for Investor Relations and Corporate Communications Services
April 21, 2026
Via
ACCESS Newswire
Lobe Sciences Ltd. Announces Non-Brokered Private Placement
April 10, 2026
Via
ACCESS Newswire
Lobe Sciences Ltd. Reports Improved Financial Position and Strategic Update
March 25, 2026
Via
ACCESS Newswire
Lobe Sciences Announces Appointment of Mr. Mirza Rahimani, CPA, CA as Chief Financial Officer
March 09, 2026
Via
ACCESS Newswire
Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
March 05, 2026
Via
ACCESS Newswire
Lobe Sciences Reports First Quarter 2026 Results and Highlights
February 03, 2026
Via
ACCESS Newswire
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
January 13, 2026
Via
ACCESS Newswire
Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy
January 08, 2026
Via
ACCESS Newswire
Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition
January 06, 2026
Via
ACCESS Newswire
Lobe Sciences Completes Debt Settlement to Improve Balance Sheet
October 23, 2025
Via
ACCESS Newswire
Lobe Sciences Improves Balance Sheet
October 09, 2025
Via
ACCESS Newswire
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
September 09, 2025
Via
ACCESS Newswire
Lobe Sciences Announces the Appointment of Marco Mastrodonato to its Board of Directors
September 08, 2025
Via
ACCESS Newswire
Lobe Sciences Announces the Closing of the Previously Announced Private Placement
August 14, 2025
Via
ACCESS Newswire
Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory
July 29, 2025
Via
ACCESS Newswire
Lobe Sciences Ltd. Announces Debt Settlement
July 16, 2025
Via
ACCESS Newswire
Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease
July 08, 2025
Via
ACCESS Newswire
Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
June 17, 2025
Via
ACCESS Newswire
Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth
June 03, 2025
Via
ACCESS Newswire
Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
April 14, 2025
Via
ACCESS Newswire
Lobe Sciences Provides Corporate Update
April 04, 2025
Via
ACCESS Newswire
Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Conjugated Psilocin™
November 18, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences, Ltd. Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin™
October 16, 2024
From
Lobe Sciences, Ltd.
Via
Business Wire
Lobe Sciences and Alera Pharma Announce Issuance of U.S. Patent for Conjugated Psilocin™
October 02, 2024
From
Lobe Sciences, Ltd.
Via
Business Wire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
